Cargando…

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis

BACKGROUND: Newer oral antidiabetic drug classes are expanding treatment options for type 2 diabetes mellitus (T2DM); however, concerns remain. The objective was to assess relative risk of heart failure hospitalization of sodium–glucose co-transporter-2 (SGLT2) and dipeptidyl peptidase-4 (DPP4) inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gautam, Santosh, Agiro, Abiy, Barron, John, Power, Thomas, Weisman, Harry, White, Jeff
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535291/ https://www.ncbi.nlm.nih.gov/pubmed/28756774 http://dx.doi.org/10.1186/s12933-017-0575-x

Ejemplares similares

Impact of Sodium Zirconium Cyclosilicate Plus Renin–Angiotensin–Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study
por: Dwyer, Jamie P., et al.
Publicado: (2023)

In-hospital mortality, length of stay, and hospitalization cost of COVID-19 patients with and without hyperkalemia
por: Amin, Alpesh, et al.
Publicado: (2022)

Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life
por: Ashana, Deepshikha Charan, et al.
Publicado: (2019)

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
por: Stapff, Manfred Paul
Publicado: (2018)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2019)

Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study
por: Agiro, Abiy, et al.
Publicado: (2023)

Gliptins: A New Class of Oral Antidiabetic Agents
por: Seshadri, K. G., et al.
Publicado: (2009)

Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients
por: Liu, Gordon, et al.
Publicado: (2021)

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia
por: Bramlage, Peter, et al.
Publicado: (2012)

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
por: Lam, Carolyn S. P., et al.
Publicado: (2021)

Initiating ivabradine during hospitalization in patients with acute heart failure: A real‐world experience in China
por: Liu, Ying‐Xian, et al.
Publicado: (2022)

Observational designs for real-world evidence studies
por: Taur, Santosh Ramesh
Publicado: (2022)

Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case–control analysis
por: Hsu, Chien-Yi, et al.
Publicado: (2016)

Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population
por: Zile, Michael R., et al.
Publicado: (2020)

Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study
por: Agiro, Abiy, et al.
Publicado: (2023)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2018)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Antibiotic dispensing following pediatric visits in the US emergency departments and outpatient settings from 2006 to 2016
por: Agiro, Abiy, et al.
Publicado: (2019)

Do Acupuncture Services Reduce Subsequent Utilization of Opioids and Surgical Interventions Compared to Noninvasive Therapies among Patients with Pain Conditions?
por: Pham, Timothy, et al.
Publicado: (2021)

Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study
por: Temelkova, Nataliya, et al.
Publicado: (2019)

Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims
por: Chen, Xiaoxue, et al.
Publicado: (2019)

Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study
por: Zerovnik, Spela, et al.
Publicado: (2021)

The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry
por: Tzamalis, Panagiotis, et al.
Publicado: (2019)

Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
por: Yabe, Daisuke, et al.
Publicado: (2020)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence
por: Bartlett, Victoria L., et al.
Publicado: (2019)

The effects of antidiabetic agents on heart failure
por: Wijnen, M., et al.
Publicado: (2021)

New York Heart Association Class and Kansas City Cardiomyopathy Questionnaire in Acute Heart Failure
por: Huo, Xiqian, et al.
Publicado: (2023)

Blood glucose may be another index to initiate insulin treatment besides glycated hemoglobin A1c after oral antidiabetic medications failure for glycemic control: A real–world survey
por: Li, Yanli, et al.
Publicado: (2022)

The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE‐UTILIZE study
por: Agiro, Abiy, et al.
Publicado: (2022)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
por: Tajima, Atsushi, et al.
Publicado: (2022)

SID-1 Domains Important for dsRNA Import in Caenorhabditis elegans
por: Whangbo, Jennifer S., et al.
Publicado: (2017)

Weight changes following antidiabetic mediation use: Real‐world evidence from health system data
por: Lyu, Beini, et al.
Publicado: (2022)

Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study
por: Camm, A. John, et al.
Publicado: (2020)

Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
por: Wallach, Joshua D., et al.
Publicado: (2021)

Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: “Real‐world” evidence
por: Chen, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t463ladoo21ga3hd3dql9ujvv5